A randomized, double blind, placebo controlled, four arm (placebo, tolterodine ER [extended release], tamsulosin, and tolterodine ER plus tamsulosin) study to evaluate the clinical efficacy and safety of tolterodine ER 4 mg in men who have frequency and urgency, with or without urinary urge incontinence, with or without bladder outlet obstruction
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Tamsulosin; Tolterodine
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms; Overactive bladder
- Focus Therapeutic Use
- 22 Mar 2007 Results data published.
- 30 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History